Literature DB >> 23067238

Inferring the metabolism of human orphan metabolites from their metabolic network context affirms human gluconokinase activity.

Óttar Rolfsson1, Giuseppe Paglia, Manuela Magnusdóttir, Bernhard Ø Palsson, Ines Thiele.   

Abstract

Metabolic network reconstructions define metabolic information within a target organism and can therefore be used to address incomplete metabolic information. In the present study we used a computational approach to identify human metabolites whose metabolism is incomplete on the basis of their detection in humans but exclusion from the human metabolic network reconstruction RECON 1. Candidate solutions, composed of metabolic reactions capable of explaining the metabolism of these compounds, were then identified computationally from a global biochemical reaction database. Solutions were characterized with respect to how metabolites were incorporated into RECON 1 and their biological relevance. Through detailed case studies we show that biologically plausible non-intuitive hypotheses regarding the metabolism of these compounds can be proposed in a semi-automated manner, in an approach that is similar to de novo network reconstruction. We subsequently experimentally validated one of the proposed hypotheses and report that C9orf103, previously identified as a candidate tumour suppressor gene, encodes a functional human gluconokinase. The results of the present study demonstrate how semi-automatic gap filling can be used to refine and extend metabolic reconstructions, thereby increasing their biological scope. Furthermore, we illustrate how incomplete human metabolic knowledge can be coupled with gene annotation in order to prioritize and confirm gene functions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23067238     DOI: 10.1042/BJ20120980

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  Sequence-based Network Completion Reveals the Integrality of Missing Reactions in Metabolic Networks.

Authors:  Elias W Krumholz; Igor G L Libourel
Journal:  J Biol Chem       Date:  2015-06-03       Impact factor: 5.157

2.  The gluconate shunt is an alternative route for directing glucose into the pentose phosphate pathway in fission yeast.

Authors:  Mark E Corkins; Stevin Wilson; Jean-Christophe Cocuron; Ana P Alonso; Amanda J Bird
Journal:  J Biol Chem       Date:  2017-06-30       Impact factor: 5.157

Review 3.  Constraint-based models predict metabolic and associated cellular functions.

Authors:  Aarash Bordbar; Jonathan M Monk; Zachary A King; Bernhard O Palsson
Journal:  Nat Rev Genet       Date:  2014-01-16       Impact factor: 53.242

4.  A community-driven global reconstruction of human metabolism.

Authors:  Ines Thiele; Neil Swainston; Ronan M T Fleming; Andreas Hoppe; Swagatika Sahoo; Maike K Aurich; Hulda Haraldsdottir; Monica L Mo; Ottar Rolfsson; Miranda D Stobbe; Stefan G Thorleifsson; Rasmus Agren; Christian Bölling; Sergio Bordel; Arvind K Chavali; Paul Dobson; Warwick B Dunn; Lukas Endler; David Hala; Michael Hucka; Duncan Hull; Daniel Jameson; Neema Jamshidi; Jon J Jonsson; Nick Juty; Sarah Keating; Intawat Nookaew; Nicolas Le Novère; Naglis Malys; Alexander Mazein; Jason A Papin; Nathan D Price; Evgeni Selkov; Martin I Sigurdsson; Evangelos Simeonidis; Nikolaus Sonnenschein; Kieran Smallbone; Anatoly Sorokin; Johannes H G M van Beek; Dieter Weichart; Igor Goryanin; Jens Nielsen; Hans V Westerhoff; Douglas B Kell; Pedro Mendes; Bernhard Ø Palsson
Journal:  Nat Biotechnol       Date:  2013-03-03       Impact factor: 54.908

5.  Comparative evaluation of open source software for mapping between metabolite identifiers in metabolic network reconstructions: application to Recon 2.

Authors:  Hulda S Haraldsdóttir; Ines Thiele; Ronan Mt Fleming
Journal:  J Cheminform       Date:  2014-01-27       Impact factor: 5.514

6.  Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v.3.0.

Authors:  Laurent Heirendt; Sylvain Arreckx; Thomas Pfau; Sebastián N Mendoza; Anne Richelle; Almut Heinken; Hulda S Haraldsdóttir; Jacek Wachowiak; Sarah M Keating; Vanja Vlasov; Stefania Magnusdóttir; Chiam Yu Ng; German Preciat; Alise Žagare; Siu H J Chan; Maike K Aurich; Catherine M Clancy; Jennifer Modamio; John T Sauls; Alberto Noronha; Aarash Bordbar; Benjamin Cousins; Diana C El Assal; Luis V Valcarcel; Iñigo Apaolaza; Susan Ghaderi; Masoud Ahookhosh; Marouen Ben Guebila; Andrejs Kostromins; Nicolas Sompairac; Hoai M Le; Ding Ma; Yuekai Sun; Lin Wang; James T Yurkovich; Miguel A P Oliveira; Phan T Vuong; Lemmer P El Assal; Inna Kuperstein; Andrei Zinovyev; H Scott Hinton; William A Bryant; Francisco J Aragón Artacho; Francisco J Planes; Egils Stalidzans; Alejandro Maass; Santosh Vempala; Michael Hucka; Michael A Saunders; Costas D Maranas; Nathan E Lewis; Thomas Sauter; Bernhard Ø Palsson; Ines Thiele; Ronan M T Fleming
Journal:  Nat Protoc       Date:  2019-03       Impact factor: 13.491

7.  Phenotypic differentiation of gastrointestinal microbes is reflected in their encoded metabolic repertoires.

Authors:  Eugen Bauer; Cedric Christian Laczny; Stefania Magnusdottir; Paul Wilmes; Ines Thiele
Journal:  Microbiome       Date:  2015-11-30       Impact factor: 14.650

Review 8.  Metabolomics and systems pharmacology: why and how to model the human metabolic network for drug discovery.

Authors:  Douglas B Kell; Royston Goodacre
Journal:  Drug Discov Today       Date:  2013-07-26       Impact factor: 7.851

9.  Promise and reality in the expanding field of network interaction analysis: metabolic networks.

Authors:  Susanna Bazzani
Journal:  Bioinform Biol Insights       Date:  2014-04-16

10.  Biochemical characterization of human gluconokinase and the proposed metabolic impact of gluconic acid as determined by constraint based metabolic network analysis.

Authors:  Neha Rohatgi; Tine Kragh Nielsen; Sara Petersen Bjørn; Ivar Axelsson; Giuseppe Paglia; Bjørn Gunnar Voldborg; Bernhard O Palsson; Óttar Rolfsson
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.